Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed: <=3.13

productUS

A product tracked in the threat graph; the vulnerabilities below are known to affect it.

KEV-listed

public exploit

EPSS ≥ 10%

by severity

3critical3high1medium0low

updated 2026-10-27

vulnerabilities (7)

Related CVEs.

sort

ID	severity	EPSS	exploitable	patched	published	affected
CVE-2015-3955US	high10.0	6.62% (94th)	—	no fix	2015-07-06	—
CVE-2015-3958US	high7.8	2.56% (85th)	—	no fix	2015-07-06	—
CVE-2015-3954US	critical9.8	2.04% (81st)	—	no fix	2019-03-25	—
CVE-2015-3953US	critical9.8OT elevated	1.97% (80th)	—	no fix	2019-03-25	—
CVE-2015-3952US	high7.5OT elevated	1.01% (63rd)	—	no fix	2019-03-25	—
CVE-2015-3956US	critical9.8OT elevated	0.95% (61st)	—	no fix	2019-03-25	—
CVE-2015-3957US	medium4.6OT elevated	0.54% (45th)	—	no fix	2015-07-06	—

The flaw types (CWEs) most of these CVEs share.

CWE-119Improper Restriction of Operations within the Bounds of a Memory Buffer1 CVEs
CWE-121Stack-based Buffer Overflow1 CVEs
CWE-19CWE-191 CVEs
CWE-200Exposure of Sensitive Information to an Unauthorized Actor1 CVEs
CWE-255CWE-2551 CVEs
CWE-259Use of Hard-coded Password1 CVEs
CWE-285Improper Authorization1 CVEs
CWE-312Cleartext Storage of Sensitive Information1 CVEs

Which sources assert this record, and when.

scry

Products carry known vulnerabilities once they are exposed to the internet. See what is exposed on your perimeter with a free passive scan.